ArticleApoptosis : an international journal on programmed cell death2026
Kaempferol protects melanocytes from ferroptosis by modulating the NF-κB/PTGS2 signaling axis in vitiligo.
Article in Apoptosis : an international journal on programmed cell death, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Natural Medicines Modulating Tumor Perineural Invasion: Regulatory Mechanisms and Therapeutic Potential.Drug design, development and therapy · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Oxidative stress-induced ferroptosis is increasingly recognized as an important contributor to melanocyte destruction in vitiligo; however, the specific upstream signaling networks linking inflammatory signaling to ferroptosis susceptibility remain incompletely defined. Kaempferol, a natural flavonoid and key bioactive constituent of the traditional herb Vernonia anthelmintica (L.) Willd., possesses antioxidant and anti-inflammatory properties, yet its potential to mitigate melanocyte ferroptosis warrants investigation. We established an RSL3 (Ras-selective lethal 3)-induced ferroptosis model in primary human melanocytes and employed a multi-dimensional approach integrating transcriptomic profiling, network pharmacology, molecular docking, and immunofluorescence analysis. Clinical relevance was validated using lesional skin tissues from vitiligo patients. RSL3 challenge triggered canonical ferroptosis features, including lethal lipid peroxidation, glutathione depletion, and characteristic mitochondrial shrinkage, all of which were significantly attenuated by kaempferol. Mechanistically, unbiased transcriptomic and network analyses identified prostaglandin-endoperoxide synthase 2 (PTGS2) as a convergent node associated with both nuclear factor-κB (NF-κB)-driven inflammatory signaling and ferroptosis stress. We found that kaempferol markedly inhibited p65 nuclear translocation, accompanied by suppression of PTGS2 transcription. Notably, pharmacological inhibition of NF-κB using BAY 11-7082 phenocopied the anti-ferroptosis efficacy of kaempferol, supporting the functional involvement of this signaling axis. Furthermore, clinical analyses revealed aberrant activation of the NF-κB/PTGS2 pathway concomitant with ferroptosis signatures in vitiligo lesions. Our findings identify ferroptosis as a critical mechanism of melanocyte injury and delineate an NF-κB/PTGS2-associated signaling framework linking oxidative stress, inflammatory activation, and ferroptosis damage. By modulating this stress-responsive axis, kaempferol confers robust protection against ferroptosis melanocyte injury, highlighting its potential relevance as a ferroptosis-modulating strategy.
Indexed as
Identifiers
41981207What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.